Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids

Journal of Lipid Research

Volumn 49, Issue 12, 2008, Pages 2557-2570

  Bai, Hyoung Woo ^a   Zhu, Bao Ting ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase activation; Prostaglandins

Indexed keywords

11 HYDROXY 5,8,10 EICOSATETRAENOIC ACID; 11 HYDROXY 5,8,10 HEPTADECATRIENOIC ACID; 12 HYDROXY 5,8,11,13 ICOSATETRAENOIC ACID; 15 HYDROXY 5,8,11,13 ICOSATETRAENOIC ACID; 5 HYDROXY 5,8,10 EICOSATETRAENOIC ACID; APIGENIN; BAICALEIN; CHRYSIN; CHRYSOERIOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DAIDZEIN; DIOSMETIN; FISETIN; FLAVANOID; GENISTEIN; ISORHAMNETIN; KAEMPFEROL; MORIN; MYRICETIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; QUERCETIN; RUTOSIDE; SILIBININ; TAMARIXETIN; UNCLASSIFIED DRUG; ARACHIDONIC ACID; FLAVONOID;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME KINETICS; ENZYME SPECIFICITY; IN VITRO STUDY; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; ANIMAL; DIET; KINETICS; METABOLISM;

ANIMALS; ARACHIDONIC ACID; CATALYSIS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIET; FLAVONOIDS; KINETICS; MICE;

EID: 59649112275     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800358-JLR200     Document Type: Article

References (59)

1. Hamberg, M., and B. Samuelsson. 1967. Oxygenation of unsaturated fatty acids by the vesicular gland of sheep. J. Biol. Chem. 242: 5344-5354.
2. Miyamoto, T., N. Ogino, S. Yamamoto, and O. Hayaishi. 1976. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 251: 2629-2636.
3. Marnett, L. J. 2000. Cyclooxygenase mechanisms. Curr. Opin. Chem. Biol. 4: 545-552.
4. Kurumbail, R. G., J. R. Kiefer, and L. J.Marnett. 2001. Cyclooxygenase enzymes: catalysis and inhibition. Curr. Opin. Struct. Biol. 22: 752-760.
5. Regan, J. W. 2003. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74: 143-153.
6. Lee, J. L., A. Kim, L. Kopelovich, D. R. Bickers, and M. Athar. 2005. Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer. J. Invest. Dermatol. 125: 818-825.
7. Sung, Y. M., G. He, and S. M. Fischer. 2005. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. Cancer Res. 65: 9304-9311.
8. Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69: 145-182.
9. Hemler, M., and W. E. Lands. 1976. Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme. J. Biol. Chem. 251: 5575-5579.
10. van der Ouderaa, F. J., M. Buytenhek, D. H. Nugteren, and D. A. Van Dorp. 1997. Purification and characterisation of prostaglandin endoperoxide synthetase from sheep vesicular glands. Biochim. Biophys. Acta. 487: 315-331.
11. Xie, W. L., J. G. Chipman, D. L. Robertson, R. L. Erikson, and D. L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA. 88: 2692-2696.
12. Kujubu, D. A., B. S. Fletcher, B. C. Varnum, R. W. Lim, and H. R. Herschman. 1991. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue. J. Biol. Chem. 266: 12866-12872.
13. O'Banion, M. K., H. B. Sadowski, V. Winn, and D. A. Young. 1991. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. Biol. Chem. 266: 23261-23267.
14. Sirois, J., and J. S. Richards. 1992. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J. Biol. Chem. 267: 6382-6388.
15. Hla, T., and K. Neilson. 1992. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA. 89: 7384-7388.
16. William, L. S., and E. M. L. William. 1971. Stimulation and blockade of prostaglandin biosynthesis. J. Biol. Chem. 246: 6700-6702.
17. Yuchiong, H., and H. B. Dunford. 1992. Prostaglandin H synthase kinetics. J. Biol. Chem. 267: 17649-17657.
18. Samuel, B., and B. Barishaw. 1949. The use of hesperidin-C in the treatment of abnormal capillary fragility. Exp. Med. Surg. 7: 358-365.
19. Terao, J., M. Piskula, andQ. Yao. 1994. Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch. Biochem. Biophys. 308: 278-284.
20. Deschner, E. E., J. Ruperto, G. Wong, and H. L. Newmark. 1991. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis. 12: 1193-1196.
21. Tzeng, S. H., W. C. Ko, F. N. Ko, and C. M. Teng. 1991. Inhibition of platelet aggregation by some flavonoids. Thromb. Res. 64: 91-100.
22. Rump, A. F., M. Schussler, D. Acar, A. Cordes, R. Ratke, M. Theisohn, R. Rosen, W. Klaus, and U. Fricke. 1995. Effects of different inotropes with antioxidant properties on acute regional myocardial ischemia in isolated rabbit hearts. Gen. Pharmacol. 26: 603-611.
23. Gil, B., M. J. Sanz, M. C. Terencio, M. L. Ferrandiz, G. Bustos, M. Paya, R. Gunasegaran, and M. J. Alcaraz. 1994. Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice. Life Sci. 54: 333-338.
24. Ferrandiz, M. L., and M. J. Alcaraz. 1991. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions. 32: 283-288.
25. Middleton, E., Jr., and C. Kandaswami. 1992. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 43: 1167-1179.
26. Di Carlo, G., N. Mascolo, A. A. Izzo, and F. Capasso. 1999. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci. 65: 337-353.
27. Hamberg, M., and B. Samuelsson. 1973. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA. 70: 899-903.
28. Baumann, J., F. von Bruchhausen, and G. Wurm. 1980. Flavonoids and related compounds as inhibition of Arachidonic acid peroxidation. Prostaglandins. 20: 627-639.
29. Kalkbrenner, F., G. Wurm, and F. von Bruchhausen. 1992. In vitro inhibition and stimulation of purified prostaglandin endoperoxide synthase by flavonoids: structure-activity relationship. Pharmacology. 44: 1-12.
30. Mahmoud, N. N., A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli. 2000. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis. 21: 921-927.
31. Welton, A. T., L. D. Tobias, C. Fiedler-Nagy, W. Anderson, W. Hope, K. Meyers, and J. W. Coffey. 1986. The effect of flavonoids on arachidonic acid metabolism. In Plant Flavonoids in Biology and Medicine. V. Cody, E. Middleton, and J. B. Harborne, editors. Alan R. Liss, New York. 231-242.
32. Chi, Y. S., H. G. Jong, K. H. Son, H. W. Chang, S. S. Kang, and H. P. Kim. 2001. Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem. Pharmacol. 62: 1185-1191.
33. + mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65: 10623-10631.
34. Kulmacz, R. J. 1986. Prostaglandin H synthase and hydroperoxides: peroxidase reaction and inactivation kinetics. Arch. Biochem. Biophys. 249: 273-285.
35. Hsuanyu, Y., and H. B. Dunford. 1990. Reactions of prostaglandin H synthase in the presence of the stabilizing agents diethyldithiocarbamate and glycerol. Biochem. Cell Biol. 68: 965-971.
36. MacDonald, I. D., G. Graff, L. A. Anderson, and H. B. Dunford. 1989. Optical spectra and kinetics of reactions of prostaglandin H synthase: effects of the substrates 13-hydroperoxyoctadeca-9,11-dienoic acid, arachidonic acid, N,N,N′,N′-tetramethyl-p-phenylenediamine, and phenol and of the nonsteroidal anti-inflammatory drugs aspirin, indomethacin, phenylbutazone, and bromfenac. Arch. Biochem. Biophys. 272: 194-202.
37. Hsuanyu, Y., and H. B. Dunford. 1992. Reduction of prostaglandin H synthase compound II by phenol and hydroquinone, and the effect of indomethacin. Arch. Biochem. Biophys. 292: 213-220.
38. Pietta, P.G. 2000. Flavonoids as antioxidants. J. Nat. Prod. 63: 1035-1042.
39. Cos, P., L. Ying, M. Calomme, J. P. Hu, K. Cimanga, B. Van Poel, L. Pieters, A. J. Vlietinck, and D. Vanden Berghe. 1998. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod. 61: 71-76.
40. Bors, W., and C. Michel. 2002. Chemistry of the antioxidant effect of polyphenols. Ann. N. Y. Acad. Sci. 957: 57-69.
41. Middleton, E., and C. Kandaswami. 1993. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In The Flavonoids: Advances in Research Since 1986. J. Harborne, editor. Chapman & Hall, London. 619-652.
42. Flower, R. J., and J. R. Vane. 1972. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 240: 410-411.
43. Gottlieb, S. 2001. COX 2 inhibitors may increase risk of heart attack. [news] BMJ. 323: 471.
44. Vane, J. R., and R. M. Botting. 1998. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47: S78-S87.
45. Schmedtje, J. F., Y. S. Ji, W. L. Liu, R. N. DuBois, and M. S. Runge. 1997. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272: 601-608.
46. Belton, O., D. Byrne, D. Kearney, A. Leahy, and D. J. Fitzgerald. 2000. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation. 102: 840-845.
47. Bravo, L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56: 317-333.
48. Chow, H. H., Y. Cai, I. A. Hakim, J. A. Crowell, F. Shahi, C. A. Brooks, R. T. Dorr, Y. Hara, and D. S. Alberts. 2003. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 9: 3312-3319.
49. Ross, J. A., and C. M. Kasum. 2002. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22: 19-34.
50. Manach, C., G. Williamson, C. Morand, A. Scalbert, and C. Rémésy. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81 (1, Suppl): 230S-242S.
51. Manach, C., A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez. 2004. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 79: 727-747.
52. Lee, M. J., Z. Y. Wang, H. Li, L. Chen, Y. Sun, S. Gobbo, D. A. Balentine, and C. S. Yang. 1995. Analysis of plasma and urinary tea polyphones in human subjects. Cancer Epidemiol. Biomarkers Prev. 4: 393-399.
53. Chow, H. H., Y. Cai, D. S. Alberts, I. Hakim, R. Dorr, F. Shahi, J. A. Crowell, C. S. Yang, and Y. Hara. 2001. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev. 10: 53-58.
54. Bors, W., and M. Saran. 1987. Radical scavenging by flavonoid antioxidants. Free Radic. Res. Commun. 2: 289-294.
55. Mira, L., M. Silva, and C. F. Manso. 1994. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem. Pharmacol. 48: 753-759.
56. Cao, G., E. Sofic, and R. L. Prior. 1997. Antioxidant and prooxidant behaviour of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22: 749-760.
57. Jovanovic, S. V., S. Steenken, M.G. Simic, and Y.Hara. 1998. Antioxidant properties of flavonoids: reduction potentials and electron transfer reactions of flavonoids radicals. In Flavonoids in Health and Disease. C. Rice-Evans and L. Packer, editors. Marcel Dekker, New York. 137-161.
58. Arora, A., M. G. Nair, and G. M. Strasburg. 1998. Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic. Biol. Med. 24: 1355-1363.
59. Mira, L., M. Silva, R. Rocha, and C. F. Manso. 1999. Measurement of relative antioxidant activity of compounds: a methodological note. Redox Rep. 4: 69-74.